1.35 lakh people have invested in this fund
1.35 lakh people have invested
in this fund as of
Total AUM
₹1,228.09 crores as of Dec 31, 2022
Age of Fund
4 years 2 months since Nov 30, 2018
Expense Ratio
2.24% as of Feb 03, 2023
Exit Load
1% upto 12 Months
Ideal holding period
10 Years+
Holdings
  as of Dec 31, 2022Sun Pharmaceutical Industries Limited
16.25%
Cipla Limited
9.08%
Apollo Hospitals Enterprise Limited
6.79%
IPCA Laboratories Limited
5.42%
Lupin Limited
5.35%
Procter & Gamble Health Limited
5.11%
Alkem Laboratories Limited
4.35%
Large Cap
40.10%
Small Cap
24.00%
Mid Cap
23.50%
Uncategorized
12.40%
Pharmaceuticals & Biotechnology
Healthcare Services
Healthcare Equipment & Supplies
Insurance
Retailing
Rolling Returns
Chirag Dagli
Vinit Sambre
Jay Kothari
Prescribed asset allocation: 80% - 100% Equity and equity related securities of pharmaceutical and healthcare companies , 0% - 20% Equity and Equity related securities of other Companies , 0% - 20% Debt, securitized debt and Money Market Securities , 0% - 10% Units of REITs & InvITs
Top holdings
Sun Pharmaceutical Industries Limited
16.25%
Cipla Limited
9.08%
Apollo Hospitals Enterprise Limited
6.79%
IPCA Laboratories Limited
5.42%
Lupin Limited
5.35%
Allocation by Market Cap
Large Cap
40.10%
Small Cap
24.00%
Mid Cap
23.50%
Uncategorized
12.40%
Top Sectors
Pharmaceuticals & Biotechnology
Healthcare Services
Healthcare Equipment & Supplies
Insurance
Mutual-funds
Top holdings
TREPS / Reverse Repo Investments / Corporate Debt Repo
4.53%
Cash & cash equivalents
-0.32%
Instrument break-up
TREPS
100.00%
Portfolio turnover ratio
0.11 last 12 months
Standard Deviation
18.82 %
Sharpe Ratio
0.99
Beta
0.78
R-Squared
85.93 %
Performance highlights over last
for
investment
Cumulative returns on
Annual returns
Current value
Historical Returns (As per SEBI format)as of with investment of₹10,000
This fund | S&P BSE HEALTHCARE (TRI) ^ | NIFTY 50 TRI # | ||||
---|---|---|---|---|---|---|
CAGR | Current Value | CAGR | Current Value | CAGR | Current Value |
Income distribution Cum Capital Withdrawal (IDCW) Distributed
Record Date | IDCW per unit | NAV Before | NAV After |
---|
Funds | Annual returns | Current Value | Absolute Growth |
---|
Date of allotment: Nov 30, 2018.
Period for which fund's performance has been provided is computed based on last day of the month-end preceding the date of advertisement
Different plans shall have a different expense structure. The performance details provided herein are of Regular Plan.
Since inception returns have been calculated from the date of allotment till June 30, 2021
Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments
Rolling returns have been calculated based on returns from regular plan growth option.
^ Fund Benchmark # Standard Benchmark
The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
There is no assurance that the investment objective of the Scheme will be realized
An open ended equity scheme investing in healthcare and pharmaceutical sector
Level of Risk in the fund
Rs. 500 Lumpsum
Rs. 500
SIP– 12 instalments
Rs. 500 Minimum Additional Purchase
1.35 lakh peoplehave invested in this fund as of